ORIGINAL RESEARCH article
Front. Oncol.
Sec. Neuro-Oncology and Neurosurgical Oncology
This article is part of the Research TopicImaging to Guide Treatment in Brain TumorsView all 7 articles
A Comprehensive Evaluation of MRI-based Radiogenomics and Prognosis Prediction in Glioma
Provisionally accepted
- 1Karolinska Institutet (KI), Solna, Sweden
- 2Stockholms Universitet, Stockholm, Sweden
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background and purpose: In gliomas, characterization of the molecular landscape plays a critical role in determining prognosis and guiding treatment regimens. Imaging biomarker models hold promise for non-invasive characterization of glioma subtypes. We, comprehensively, assessed the potential of magnetic resonance imaging (MRI) data for predicting the survival status and molecular subtypes of glioma. Methods: We introduce a novel method for quantifying the spatial distribution of gliomas within brain anatomy. The method measures the volumetric ratio of 32 brain anatomical structures affected by the tumor. This novel feature set was combined with established radiomics to build models for predicting O6-methylguanine-DNA methyltransferase (MGMT) methylation status, isocitrate dehydrogenase (IDH) mutation status, and Overall Survival (OS) time of glioma patients. The performance of these models was evaluated on preoperative MRIs of 1788 subjects from four independent datasets, employing both cross-validation (CV) and cross-dataset evaluation strategies. Results: The proposed feature set revealed no regular patterns in tumor locations across the brain. Integration of these features with radiomics improved model performance for the three tasks. The best performance, in terms of AUROC, respectively, for CV and cross-data tests were: 0.685 and 0.628 for MGMT status, 0.972 and 0.764 for IDH status, and 0.748 and 0.719 for OS time status. Conclusions: Our experiments demonstrate the potential of imaging biomarkers for IDH prediction, highlighting the challenges associated with predicting MGMT and OS only from image data. This underscores the need for additional information beyond MRI, for accurate prediction of these prognostic markers.
Keywords: brain segmentation, Glioma, radiogenomics, Radiomics, Survival status
Received: 04 Aug 2025; Accepted: 08 Dec 2025.
Copyright: © 2025 Astaraki, Lazzeroni and Toma-Dasu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Mehdi Astaraki
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.